Is BEGRX or JNJ a better dividend investment in 2026?

BEGRX currently yields 13.44% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BEGRX offers higher current income.

What is the dividend yield difference between BEGRX and JNJ?

BEGRX has a forward dividend yield of 13.44% ($2.41/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 10.08 percentage points.

Home › Compare › BEGRX vs JNJ

BEGRX vs JNJ: Dividend Comparison 2026

BEGRX yields 13.44% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BEGRX wins by $28.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BEGRX

● Live price

13.44%

Share price

$17.92

Annual div

$2.41

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$48.4K

Annual income

$3,095.72

Full BEGRX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BEGRX vs JNJ

📍 BEGRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BEGRX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BEGRX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BEGRX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BEGRX

Annual income on $10K today (after 15% tax)

$1,142.28/yr

After 10yr DRIP, annual income (after tax)

$2,631.36/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, BEGRX beats the other by $1,927.75/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BEGRX + JNJ for your $10,000?

BEGRX: 50%JNJ: 50%

100% JNJ50/50100% BEGRX

Portfolio after 10yr

$34.2K

Annual income

$1,961.75/yr

Blended yield

5.73%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BEGRX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BEGRX buys

JNJ buys

No recent congressional trades found for BEGRX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBEGRXJNJ

Forward yield	13.44% ✓	3.36%
Annual dividend / share	$2.41	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$48.4K ✓	$20.0K
Annual income after 10y	$3,095.72 ✓	$827.78
Total dividends collected	$21.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BEGRX vs JNJ ($10,000, DRIP)

Year	BEGRX Portfolio	BEGRX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,044	$1,343.86	$10,676	$355.77	+$1.4K → BEGRX
2	$14,400	$1,512.64	$11,407	$389.39	+$3.0K → BEGRX
3	$17,098	$1,690.19	$12,198	$426.53	+$4.9K → BEGRX
4	$20,170	$1,875.61	$13,056	$467.62	+$7.1K → BEGRX
5	$23,650	$2,067.90	$13,987	$513.12	+$9.7K → BEGRX
6	$27,572	$2,266.04	$14,998	$563.56	+$12.6K → BEGRX
7	$31,970	$2,468.95	$16,098	$619.52	+$15.9K → BEGRX
8	$36,884	$2,675.58	$17,295	$681.69	+$19.6K → BEGRX
9	$42,351	$2,884.84	$18,599	$750.82	+$23.8K → BEGRX
10	$48,411	$3,095.72	$20,022	$827.78	+$28.4K → BEGRX

BEGRX vs JNJ: Complete Analysis 2026

BEGRX — Stock

The fund invests primarily in equity securities (including securities convertible into, or that the investment manager expects to be exchanged for, common or preferred stock) of U.S. and foreign companies that the investment manager believes are available at market prices less than their value based on certain recognized or objective criteria (fundamental value). The equity securities in which the fund invests are primarily common stock. The fund may invest substantially and potentially up to 100% of its assets in foreign securities and participations in foreign government debt.

Full BEGRX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BEGRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BEGRX vs SCHD BEGRX vs JEPI BEGRX vs O BEGRX vs KO BEGRX vs MAIN BEGRX vs ABBV BEGRX vs MRK BEGRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.